NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

Grant Name
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Funder
HHS-NIH11(National Institutes of Health)
Research Field
Health
Deadline
April 5, 2024
Grant Size
$1,000,000
Contact Info
National Institutes of Health grantsinfo@nih.gov
Eligibility
Small businesses, Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Grant Number
PAR-21-224
Description
This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).

Funding resources

NIH General Instructions Download File
NIH Application Guide Open Link
Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

April 5, 2024

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

Related opportunities

Open Technology Programme 2023
Earth sciences December 15, 2023 €27,900,000
MRFF Clinical Trials Activity Initiative – 2023 International Clinical Trial Collaborations Grant Opportunity
Medical Research 7-Feb-2024 $12,600,000.00
2023 COVID-19 Aged Care Support Program
Aged Care 3-Apr-2024 $428,780,000.00
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Health Apr 05, 2024 12:00:00 AM EDT $1,000,000
Australian National Aged Care Classification (AN-ACC) Transition Fund
Aged Care 30-Jun-2024 $55,440,000.00
Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
Health Jan 17, 2025 12:00:00 AM EST $325,000
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
Health May 28, 2025 12:00:00 AM EDT $1,500,000
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $300,000
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale)
Medicine September 30, 2025 Up to 200,000,000 USD